Table 1. Baseline characteristics of patients.
| Variable | Value (n = 25) |
|---|---|
| Age (years) | 45.5±13.8 |
| Male sex, n (%) | 19 (76) |
| BMI (kg/m²) | 24.9±3.7 |
| Neck circumference (cm) | 37 (36–38.3) |
| Waist circumference (cm) | 93.6±8.7 |
| Etiology | |
| Idiopathic, n (%) | 19 (76) |
| Tuberculosis, n (%) | 3 (12) |
| Postoperative, n (%) | 1 (4) |
| Systemic inflammatory disease, n (%) | 2 (8) |
| Symptom time (months) | 24 (12–36) |
| NYHA functional class III/IV, n (%) | 14 (56) |
| Ascites, n (%) | 18 (72) |
| Lower limb edema, n (%) | 22 (88) |
| Cardiac resonance | |
| LVEF (%) | 58±11 |
| Pericardial thickening (mm) | 7.2±3.6 |
| Septal bounce, n (%) | 23 (92) |
| Respiratory variation in Inferior vena cava, n (%) | 23 (92) |
| Pericardial LGE | 6 (24) |
| Myocardial LGE | 2 (8) |
| Chest Radiograph—pericardial calcification, n (%) | 11 (44) |
| Hypertension, n (%) | 4 (16) |
| Diabetes, n (%) | 2 (8) |
| Smoking, n (%) | 5 (20) |
| Atrial fibrillation, n (%) | 10 (40) |
| Furosemide (mg) | 40 (30–80) |
| Spironolactone (mg) | 25 (0–62.5) |
| BNP (pg/mL) | 143 (83.5–209.5) |
| CRP (mg/dL) | 5.4 (3–10) |
| Creatinine (mg/dL) | 1 (1–1.2) |
| Hemoglobin (g/dL) | 13.7±2 |
Data with normal distribution are presented as the mean ± standard deviation. Data with abnormal distribution are presented as the median and interquartile range. BMI: body mass index; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; LGE: late gadolinium enhancement; BNP: B-type natriuretic peptide; CRP: C-reactive protein